Abattis Announces Appointment of Jim Irving
September 17, 2015 (Source: Abattis Bioceuticals Corp.) — Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (OTCQX: ATTBF) (CSE: ATT), is a Company that develops and commercializes natural health (nutraceutical) products. Abattis conducts research and development to create plant-based (botanical) intellectual property, and ingredients for the pharmaceutical, nutraceutical, bioceutical and cosmetic markets; some of which will contain cannabinoid compounds, would like to announce the appointment of Mr. Jim Irving to our Board of Directors, effective immediately.
Mr. Irving is the Director of Fundraising & Sponsorship at the BC Hospitality Foundation. The Foundation provides financial support for individuals within the hospitality industry coping with financial crisis arising from a medical condition or injury. The BCHF also awards scholarships in hospitality, culinary, sommelier and beverage programs. Jim’s background includes nearly 30 successful years of experience in the Canadian alcohol beverage industry. Jim has been a sales and marketing manager for wine and spirit agencies and breweries as well as the Canadian president of a luxury vodka brand. Jim’s past experience includes the general manager in Canada for Precept Wine, the largest privately owned wine company in the US Pacific Northwest, based in Seattle. Jim specializes in brand marketing, retail sales and packaged goods. He has excellent business skills and extensive industry contacts.
We look forward to linking Mr. Irving’s industry experience in the sales and beverage component of our Company. He will help us finalize activities for our beverage product, which are directly linked to our goal of creating long term revenues from our ingredients and products.
About Abattis Bioceuticals Corp.
Abattis is a specialty biotechnology company that aggregates, incubates, integrates, and invests in the botanical drug development industry. The Company develops and licenses natural health products, medicines, extractions, and ingredients for the biologics, nutraceutical, bioceutical, and cosmetic markets – some of which will contain cannabinoid compounds. The Company also has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding botanical drug market. We follow strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions. For more information, visit the Company’s website at:www.abattis.com.
ON BEHALF OF THE BOARD
Get our daily investorintel update
Bill Fleming, CEO
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
FORWARD LOOKING INFORMATION
This press release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Company’s Management’s Discussion and Analysis under the Company’s profile on www.sedar.com. While the Company may elect to, it does not undertake to update this information at any particular time.
Raj Shah has professional experience working for over a half a dozen years at financial firms such as Merrill Lynch and First Allied Securities Inc., ... <Read more about Raj Shah>